Mo Movassaghi

Professor

Department
Department of Chemistry
Technology Areas
Chemicals & Materials: Catalysis & Synthesis / Therapeutics: Small Molecules, Cell Based Therapy / Biotechnology: Biomanufacturing, Synthetic Biology / Drug Discovery and Research Tools: Cell Interrogation

Technologies

Synthesis and Anticancer Activity of Agelastatin Alkaloids

Technology / Case number: #16512J
Mo Movassaghi / Paul Hergenrother
Technology Areas: Therapeutics
Impact Areas: Healthy Living
Labels
  • Women's Health
License

Synthesis and Anticancer Activity of Epipolythiodiketopiperazine Alkaloids

Technology / Case number: #16016J
Mo Movassaghi / Karen Morrison / Paul Hergenrother / Justin Kim / Nicolas Boyer
Technology Areas: Biotechnology / Drug Discovery and Research Tools
Impact Areas: Healthy Living
License

Synthesis of Potent Epidithiodiketopiperazines Designed for Facile Derivatization

Technology / Case number: #21469
Mo Movassaghi / Tony Scott / Chase Olsson / Jaime Cheah / Joshua Payette
Technology Areas: Chemicals & Materials / Therapeutics
Impact Areas: Healthy Living
License

Compounds, Compositions, and Methods of Macrocyclic Depsipeptide Antibiotics

Technology / Case number: #23104
Mo Movassaghi / Kyan D'Angelo / Carly Schissel / Bradley L. Pentelute
Technology Areas: Chemicals & Materials / Therapeutics
Impact Areas: Healthy Living
License

Convergent and Biomimetic Enantioselective Total Synthesis of (-)-Communesin F

Technology / Case number: #18676
Mo Movassaghi / Wen-Tau Chang / Matthew Pompeo / Stephen Lathrop
Technology Areas: Chemicals & Materials / Therapeutics
Impact Areas: Healthy Living
License

Potent Agelastatin Derivatives as Modulators for Cancer Invasion and Metastasis

Technology / Case number: #19505J
Mo Movassaghi / Kun Xu / Alyssa Antropow / Rachel Buchsbaum
Technology Areas: Therapeutics
License

Diazene Directed Modular Synthesis of Oligocyclotryptamines

Technology / Case number: #18747
Mo Movassaghi / Petra Lindovska
Technology Areas: Biotechnology / Chemicals & Materials / Therapeutics
License

Sign up for technology updates

Sign up now to receive the latest updates on cutting-edge technologies and innovations.